3-Fluoroamphetamine

3-Fluoroamphetamine
Clinical data
Trade names3FPPA
Addiction
liability
moderate
Routes of
administration
Oral
Legal status
Legal status
Pharmacokinetic data
Onset of action20 - 60 minutes
Elimination half-life90 minutes
Duration of action2 - 3 hours "3-FA". Psychonautwiki.
Identifiers
  • (RS)-1-(3-Fluorophenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H12FN
Molar mass153.200 g·mol−1
3D model (JSmol)
Density1.0  g/cm3
Boiling point208.2 °C (406.8 °F)
  • Fc1cccc(c1)CC(C)N
  • InChI=1S/C9H12FN/c1-7(11)5-8-3-2-4-9(10)6-8/h2-4,6-7H,5,11H2,1H3 Y
  • Key:PIOCLGPCMNPZFT-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

3-Fluoroamphetamine (3-FA; PAL-353) is a stimulant drug from the amphetamine family which acts as a monoamine releaser with similar potency to methamphetamine but more selectivity for dopamine and norepinephrine release over serotonin. It is self-administered by mice to a similar extent to related drugs such as 4-fluoroamphetamine and 3-methylamphetamine.

3-Fluoroamphetamine often found its use as a designer drug in several studies to mimic the effects of illegal amphetamines. It has also appeared on the drug market for recreational use as an amphetamine alternative, its has been reported in January 2009 to the European Early Warning System by Belgium. Little is known about the exact history of this compound.